XML 69 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Information With Respect to Stock Options
The below tables present information with respect to stock options:
(in thousands, except for exercise price)Number of SharesWeighted
Average
Exercise Price		Aggregate
 Intrinsic Value
Outstanding at January 1, 20231,029 $12.82 
Options exercised(97)10.73 
Options canceled/forfeited(12)13.40 
Outstanding at December 31, 2023920 $13.04 $28,053 
Vested and expected to vest at December 31, 2023920 $13.04 $28,046 
Total shares exercisable at December 31, 2023898 $13.12 $27,299 
Shares remaining available for future grant— 

(in thousands, except for grant date fair value)202320222021
Option expense recorded, in thousands, for the year ended December 31,$2,814 $5,664 $9,585 
Weighted average grant date fair value$— $— $60.48 
Total intrinsic value of stock options exercised, in thousands, for the year ended December 31,$2,700 $4,000 $6,000 
Cash received for options exercised$1,069 $1,286 $1,156 
Schedule of Assumptions for Fair Value of Options at the Date of the Grant
Issuance date fair value of the Warrant was determined to be $14.3 million based on using the Black-Scholes model with the following assumptions:

Expected term5.0 years
Risk free interest rate0.85 %
Expected volatility53.78 %
Expected dividend yieldNone
Fair value (per warrant)$28.65 
The fair value of options at the date of the grant was estimated using the Black-Scholes model with the following assumptions for the period ending December 31, 2021:

2021
Expected option life3.1 years
Weighted average risk-free interest rate0.4 %
Weighted average expected volatility56.5 %
Expected dividend yieldNone
Schedule of Share-based Compensation by Exercise Price Range Stock options outstanding at December 31, 2023 are summarized as follows:
Range of exercise pricesNumber outstanding (in thousands)Weighted average remaining life
$0.73 - $35.26
920 5.95 years
Summary of Restricted Stock Awards Activity
Current year activity with respect to the Company’s non-vested RSUs is as follows:

(in thousands, except weighted average fair value)SharesWeighted Average grant- date fair value
Balance at January 1, 2023512 $35.96 
Granted625 35.74 
Vested(210)34.10 
Canceled/forfeited(88)38.17 
Balance at December 31, 2023839 $35.83 
The below table presents information with respect to RSUs:

(in thousands)202320222021
Service-based RSU$9,325 $6,775 $3,353 
Performance-based RSU2,257 836 839 
Total stock-based compensation expense related to RSUs$11,582 $7,611 $4,192